🔗 Visit the ClinicalTrials.gov page for NCT01374750
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends. | J Hepatol | 2013 | 1.22 |
| 2 | The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence. | J Transplant | 2014 | 0.86 |
| 3 | Molecular pathways: PI3K pathway phosphatases as biomarkers for cancer prognosis and therapy. | Clin Cancer Res | 2014 | 0.83 |
| 4 | Targeted therapies in the treatment of advanced hepatocellular carcinoma. | Clin Med Insights Oncol | 2013 | 0.83 |